Prototype of an evidence‐based tool to aid individualized treatment for type 2 diabetes-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Prototype of an evidence‐based tool to aid individualized treatment for type 2 diabetes

Published:2021-05-04 Issue:7 Volume:23 Page:1666-1671
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obes Metab

Author:

Buse John B.¹^ORCID,Holst Ingrid²,Knop Filip K.³⁴⁵⁶,Kvist Kajsa²,Thielke Desirée²,Pratley Richard⁷

Affiliation:

1. University of North Carolina School of Medicine Chapel Hill North Carolina USA

2. Novo Nordisk A/S Søborg Denmark

3. Gentofte Hospital University of Copenhagen Hellerup Denmark

4. Steno Diabetes Center Copenhagen Gentofte Denmark

5. Department of Clinical Medicine, Faculty of Health and Medical Sciences University of Copenhagen Copenhagen Denmark

6. Novo Nordisk Center for Basic Metabolic Research, Faculty of Health and Medical Sciences University of Copenhagen Copenhagen Denmark

7. AdventHealth Translational Research Institute Orlando Florida USA

Funder

National Institutes of Health

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dom.14381

Reference10 articles.

1. 1. Improving care and promoting health in populations: standards of medical Care in Diabetes—2020;American Diabetes Association;Diabetes Care,2020

2. Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

3. 2019 Update to: Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

4. Precision Medicine in Type 2 Diabetes: Using Individualized Prediction Models to Optimize Selection of Treatment

5. D'AgostinoRB Vasan RS Pencina MJ et al. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation.2008;117(6):743‐753.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association between clinical and laboratory factors and response to sodium-glucose cotransporter 2 inhibitors in patients with type 2 diabetes: a retrospective observational study;Expert Opinion on Pharmacotherapy;2024-05-23

2. Exploration of decision aids to support advance care planning: A scoping review;Journal of Clinical Nursing;2024-04-25

3. Artificial intelligence, machine learning, and deep learning in liver transplantation;Journal of Hepatology;2023-06

4. Understanding the place for GLP‐1RA therapy: Translating guidelines for treatment of type 2 diabetes into everyday clinical practice and patient selection;Diabetes, Obesity and Metabolism;2021-09

5. Generalized edema and heart failure caused from hypothyroidism and ferrous agent for hypochromic anemia;Endocrinology&Metabolism International Journal;2021-05-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3